78 related articles for article (PubMed ID: 32743573)
1. Rescue of SARS-CoV-2 from a single bacterial artificial chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
bioRxiv; 2020 Jul; ():. PubMed ID: 32743573
[TBL] [Abstract][Full Text] [Related]
2. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
[TBL] [Abstract][Full Text] [Related]
3. Generation of Recombinant SARS-CoV-2 Using a Bacterial Artificial Chromosome.
Chiem K; Ye C; Martinez-Sobrido L
Curr Protoc Microbiol; 2020 Dec; 59(1):e126. PubMed ID: 33048448
[TBL] [Abstract][Full Text] [Related]
4. Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes.
Ye C; Martinez-Sobrido L
Microbiol Spectr; 2022 Dec; 10(6):e0273222. PubMed ID: 36342302
[TBL] [Abstract][Full Text] [Related]
5. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes.
Chiem K; Morales Vasquez D; Park JG; Platt RN; Anderson T; Walter MR; Kobie JJ; Ye C; Martinez-Sobrido L
J Virol; 2021 Mar; 95(7):. PubMed ID: 33431557
[TBL] [Abstract][Full Text] [Related]
6. Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus.
Chiem K; Park JG; Morales Vasquez D; Plemper RK; Torrelles JB; Kobie JJ; Walter MR; Ye C; Martinez-Sobrido L
Microbiol Spectr; 2022 Oct; 10(5):e0237922. PubMed ID: 35980204
[TBL] [Abstract][Full Text] [Related]
7. Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2.
Chiem K; Nogales A; Almazán F; Ye C; Martínez-Sobrido L
Methods Mol Biol; 2024; 2733():133-153. PubMed ID: 38064031
[TBL] [Abstract][Full Text] [Related]
8. Cloning of a Passage-Free SARS-CoV-2 Genome and Mutagenesis Using Red Recombination.
Herrmann A; Jungnickl D; Cordsmeier A; Peter AS; Überla K; Ensser A
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638527
[TBL] [Abstract][Full Text] [Related]
9. Towards a more effective strategy for COVID-19 prevention (Review).
Szkaradkiewicz-Karpińska AK; Szkaradkiewicz A
Exp Ther Med; 2021 Jan; 21(1):33. PubMed ID: 33262819
[TBL] [Abstract][Full Text] [Related]
10. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo.
DeDiego ML; Alvarez E; Almazán F; Rejas MT; Lamirande E; Roberts A; Shieh WJ; Zaki SR; Subbarao K; Enjuanes L
J Virol; 2007 Feb; 81(4):1701-13. PubMed ID: 17108030
[TBL] [Abstract][Full Text] [Related]
11. Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice.
Pruijssers AJ; George AS; Schäfer A; Leist SR; Gralinksi LE; Dinnon KH; Yount BL; Agostini ML; Stevens LJ; Chappell JD; Lu X; Hughes TM; Gully K; Martinez DR; Brown AJ; Graham RL; Perry JK; Du Pont V; Pitts J; Ma B; Babusis D; Murakami E; Feng JY; Bilello JP; Porter DP; Cihlar T; Baric RS; Denison MR; Sheahan TP
bioRxiv; 2020 Apr; ():. PubMed ID: 32511392
[TBL] [Abstract][Full Text] [Related]
12. A comparison of COVID-19, SARS and MERS.
Hu T; Liu Y; Zhao M; Zhuang Q; Xu L; He Q
PeerJ; 2020; 8():e9725. PubMed ID: 32879801
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries.
Elshabrawy HA
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32585913
[TBL] [Abstract][Full Text] [Related]
14. Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling.
Wehbe Z; Hammoud S; Soudani N; Zaraket H; El-Yazbi A; Eid AH
Front Pharmacol; 2020; 11():836. PubMed ID: 32581799
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Outbreak in Malaysia.
Elengoe A
Osong Public Health Res Perspect; 2020 Jun; 11(3):93-100. PubMed ID: 32494567
[TBL] [Abstract][Full Text] [Related]
16. Immunization with recombinant accessory protein-deficient SARS-CoV-2 protects against lethal challenge and viral transmission.
Ye C; Park JG; Chiem K; Dravid P; Allué-Guardia A; Garcia-Vilanova A; Kapoor A; Walter MR; Kobie JJ; Plemper RK; Torrelles JB; Martinez-Sobrido L
bioRxiv; 2022 Mar; ():. PubMed ID: 35313573
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model.
Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher P; Villano J; Littlefield K; Castillo J; Marinho P; Jedlicka A; Ordonez A; Majewska N; Betenbaugh M; Flavahan K; Mueller A; Looney M; Quijada D; Mota F; Beck SE; Brockhurst JK; Braxton A; Castell N; D'Alessio F; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL
bioRxiv; 2021 Apr; ():. PubMed ID: 33821269
[TBL] [Abstract][Full Text] [Related]
18. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.
Rosenke K; Meade-White K; Letko M; Clancy C; Hansen F; Liu Y; Okumura A; Tang-Huau TL; Li R; Saturday G; Feldmann F; Scott D; Wang Z; Munster V; Jarvis MA; Feldmann H
bioRxiv; 2020 Sep; ():. PubMed ID: 32995767
[TBL] [Abstract][Full Text] [Related]
19. Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2.
Stefanik M; Strakova P; Haviernik J; Miller AD; Ruzek D; Eyer L
Microorganisms; 2021 Feb; 9(3):. PubMed ID: 33668694
[TBL] [Abstract][Full Text] [Related]
20. Reverse genetic systems of SARS-CoV-2 for antiviral research.
Kurhade C; Xie X; Shi PY
Antiviral Res; 2023 Feb; 210():105486. PubMed ID: 36657881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
